HOPA Abstracts

Updates on Immunotherapy in Advanced Melanoma

At the 2018 Hematology/Oncology Pharmacy Association Annual Conference, Jaime Anderson, PharmD, BCOP, reviewed recent efficacy and safety data on immune checkpoint inhibitor regimens in melanoma, and discussed disease-specific characteristics that may guide treatment-planning decisions.

Targeting FMS-Like Tyrosine Kinase 3 in the Management of Patients with FLT3-Positive Acute Myeloid Leukemia

Meg Barbor, MPH

At the 2018 Hematology/Oncology Pharmacy Association Annual Conference, Dr Seddon provided attendees with an overview of FLT3-mutated AML, including currently available treatments, mechanisms of resistance, and future directions.

The Strengths and Pitfalls of PD-L1 as a Biomarker for Immunotherapy

Meg Barbor, MPH

At the 2018 Hematology/Oncology Pharmacy Association Annual Conference, Josiah Land, PharmD, BCOP, and Jacob Kettle, PharmD, BCOP, discussed the realities of using PD-L1 as a biomarker in oncology in the front- and second-line settings.

Centers for Disease Control and Prevention Guidelines on Opioid Use for Cancer Pain

Chase Doyle

The United States may be in the midst of an opioid epidemic, but the undertreatment of pain remains an issue for patients with cancer.

Maintenance Chemotherapy After Hematopoietic Stem-Cell Transplantation

Chase Doyle

Although transplantation offers cures or durable remissions for malignancies, relapse is a frequent occurrence in many diseases, and remains a major cause of mortality.

Graft-versus-Host Disease: Breakthroughs on the Horizon

Chase Doyle

Despite significant progress in stem-cell transplantations over the past decade, graft-versus-host disease (GVHD) remains the leading cause of nonrelapse death in this patient population.

Basket Clinical Trials: A New Era in Cancer Treatment

Chase Doyle

Precision medicine continues to transform oncology, and it is not just the treatments that are changing.

Burnout Rates High for Pharmacists in Hematopoietic Stem-Cell Transplantation

Chase Doyle

According to the results of a recent survey of hematopoietic stem-cell transplantation (HSCT) professionals, burnout is prevalent across all HSCT disciplines, with pharmacists showing the highest rates of burnout and moral distress.

Chemotherapy Treatment Considerations in Special Patient Populations

Chase Doyle

The overtreatment or undertreatment of patients with cancer can have life-or-death implications.

A Conversation with Patrick J. Medina, PharmD, BCOP

Patrick J. Medina, PharmD, BCOP, is Professor of Clinical and Administrative Sciences at the University of Oklahoma College of Pharmacy in Tulsa.

Page 2 of 3
Results 11 - 20 of 23

HOPA Abstracts

I'd like to receive: